Service Members Have Until June 30th To Participate In Medical Experimentation Or Senior Pentagon Leadership Will Initiate Court-Martial Proceedings


June 27, 2022

SECDEF Austin and Senior Pentagon Leadership have given an estimated 2.1 million service members until June 30 to participate in experimental drugs, or they will face punitive actions, including possible criminal proceedings.

To the shock of service members, Senior Pentagon Leadership is ignoring a 2005 FDA directive to the DoD that “refusal [to participate in investigational drugs] may not be grounds for any disciplinary action under the Uniform Code of Military Justice.” In addition, SECDEF Austin and his subordinates are flat out ignoring a 2005 court ruling that “Congress has prohibited the administration of investigational [experimental] drugs to service members without their consent.” One service member said, “it’s as if there is no more accountability in the military.”

Military directives issued by all branches require service members to participate in one of the following experimental drugs by June 30: 1) Investigational drug ID 19736, 2) Investigational drug ID 22657, or 3) Investigational drug ID 19745. These drugs have not been approved by the FDA, have no legal intent, and come with inherent risks such as death and/or permanent disability. 1st Lt. Mark Bashaw, U.S. Army Preventive Medicine Officer, told CovidPenalty.com, “The Defense Medical Epidemiological Database (DMED) is showing a 1,164% increase in adverse events in 2021 compared to the last 24 years of data (1977-2021) when comparing these experimental drugs to FDA-approved drugs. These drugs are deadly and dangerous, and this experimental campaign must be halted immediately, cease and desist!”

SECDEF issued an order on August 24, 2021, to his commanders that they may not use experimental drugs in mandates. However, he is now blindly allowing his generals to penalize service members under the Uniform Code of Military Justice because they refuse to participate in medical experimentation.

Dr. Terry Adirim, the former Health Assistant to the Secretary of Defense, issued a memorandum to the military commands in 2021 that DoD health providers “will” use experimental drugs “as if” they are FDA-approved drugs. Her guidance to pretend experimental drugs are the same as licensed drugs violates an international treaty, federal law, and military regulations. However, Senior Pentagon Leadership, the Office of Inspector General, and JAG refused to correct Dr. Adirim’s memorandum. Instead, they used her directive as the basis to engage in gross abuse of human rights not seen since the Nuremberg Trials.

Military regulations stipulate that service members who refuse the administration of an experimental drug “may not incur a penalty or lose a benefit to which they are otherwise entitled.” Service members expressed immense frustration and anger over the apparent callousness of commanders who care more about Senior Pentagon Leadership’s political goals than their brothers-in-arms’ health, safety, and rights.